DOSSIER · 13F Holders · Q1 2026Healthcare · Biological Products, (No Diagnostic Substances)
APGE
APOGEE THERAPEUTICS INC
257 institutions still hold APOGEE THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 03770N101·Biological Products, (No Diagnostic Substances)·257 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
257 institutions reported APGE in Q1 2026. T. Rowe Price Investment Management, Inc. leads at 15.8% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 13
237 more holders available. Log in →